10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine

C290H244N20O4 — CID 157094623

IUPAC10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine
SMILESCc1ccc(N(c2ccccc2)c2ccc(-c3ccc4c(c3)c3ccccc3n4C)cc2)cc1.Cc1ccc(N(c2ccccc2)c2ccc3c(c2)C(C)(C)c2cc(N(c4ccccc4)c4ccccc4)ccc2N3C)cc1.Cc1ccc(N(c2ccccc2)c2ccc3c(c2)Oc2cc(N(c4ccccc4)c4ccccc4)ccc2N3C)cc1.Cc1ccc2c(c1)C(C)(C)c1cc(C)ccc1N2c1ccc2c(c1)C(C)(C)c1cc(N3c4ccccc4C(C)(C)c4ccccc43)ccc1N2C.Cc1ccc2c(c1)Oc1cc(C)ccc1N2c1ccc2c(c1)Oc1cc(N3c4ccccc4Oc4ccccc43)ccc1N2C.Cn1c2ccc(-c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)cc2c2cc(-c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)ccc21.Cn1c2ccc(N(c3ccccc3)c3ccccc3)cc2c2cc(N(c3ccccc3)c3ccccc3)ccc21
InChIInChI=1S/C55H45N3.C48H47N3.C41H37N3.C39H29N3O3.C38H31N3O.C37H29N3.C32H26N2/c1-54(2)44-14-6-10-18-50(44)57(51-19-11-7-15-45(51)54)40-28-22-36(23-29-40)38-26-32-48-42(34-38)43-35-39(27-33-49(43)56(48)5)37-24-30-41(31-25-37)58-52-20-12-8-16-46(52)55(3,4)47-17-9-13-21-53(47)58;1-30-18-22-44-36(26-30)47(5,6)37-27-31(2)19-23-45(37)51(44)33-21-25-41-39(29-33)48(7,8)38-28-32(20-24-40(38)49(41)9)50-42-16-12-10-14-34(42)46(3,4)35-15-11-13-17-43(35)50;1-30-20-22-34(23-21-30)44(33-18-12-7-13-19-33)36-25-27-40-38(29-36)41(2,3)37-28-35(24-26-39(37)42(40)4)43(31-14-8-5-9-15-31)32-16-10-6-11-17-32;1-24-12-16-32-36(20-24)44-37-21-25(2)13-17-33(37)42(32)27-15-19-29-39(23-27)45-38-22-26(14-18-28(38)40(29)3)41-30-8-4-6-10-34(30)43-35-11-7-5-9-31(35)41;1-28-18-20-32(21-19-28)41(31-16-10-5-11-17-31)34-23-25-36-38(27-34)42-37-26-33(22-24-35(37)39(36)2)40(29-12-6-3-7-13-29)30-14-8-4-9-15-30;1-38-36-24-22-32(39(28-14-6-2-7-15-28)29-16-8-3-9-17-29)26-34(36)35-27-33(23-25-37(35)38)40(30-18-10-4-11-19-30)31-20-12-5-13-21-31;1-23-12-17-27(18-13-23)34(26-8-4-3-5-9-26)28-19-14-24(15-20-28)25-16-21-32-30(22-25)29-10-6-7-11-31(29)33(32)2/h6-35H,1-5H3;10-29H,1-9H3;5-29H,1-4H3;4-23H,1-3H3;3-27H,1-2H3;2-27H,1H3;3-22H,1-2H3
InChIKeyAFBHCAFVFBRCMD-UHFFFAOYSA-N
MW4073.28 g/mol
LogP80.34
Rot. Bonds30

About 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine

10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine (PubChem CID 157094623) has the molecular formula C290H244N20O4 and a molecular weight of 4073.28 g/mol. Its IUPAC name is 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine.

Molecular Properties

Compound Name10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine
PubChem CID157094623
Molecular FormulaC290H244N20O4
Molecular Weight4073.28 g/mol
Exact Mass4069.95
IUPAC Name10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine
SMILESCc1ccc(N(c2ccccc2)c2ccc(-c3ccc4c(c3)c3ccccc3n4C)cc2)cc1.Cc1ccc(N(c2ccccc2)c2ccc3c(c2)C(C)(C)c2cc(N(c4ccccc4)c4ccccc4)ccc2N3C)cc1.Cc1ccc(N(c2ccccc2)c2ccc3c(c2)Oc2cc(N(c4ccccc4)c4ccccc4)ccc2N3C)cc1.Cc1ccc2c(c1)C(C)(C)c1cc(C)ccc1N2c1ccc2c(c1)C(C)(C)c1cc(N3c4ccccc4C(C)(C)c4ccccc43)ccc1N2C.Cc1ccc2c(c1)Oc1cc(C)ccc1N2c1ccc2c(c1)Oc1cc(N3c4ccccc4Oc4ccccc43)ccc1N2C.Cn1c2ccc(-c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)cc2c2cc(-c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)ccc21.Cn1c2ccc(N(c3ccccc3)c3ccccc3)cc2c2cc(N(c3ccccc3)c3ccccc3)ccc21
InChIInChI=1S/C55H45N3.C48H47N3.C41H37N3.C39H29N3O3.C38H31N3O.C37H29N3.C32H26N2/c1-54(2)44-14-6-10-18-50(44)57(51-19-11-7-15-45(51)54)40-28-22-36(23-29-40)38-26-32-48-42(34-38)43-35-39(27-33-49(43)56(48)5)37-24-30-41(31-25-37)58-52-20-12-8-16-46(52)55(3,4)47-17-9-13-21-53(47)58;1-30-18-22-44-36(26-30)47(5,6)37-27-31(2)19-23-45(37)51(44)33-21-25-41-39(29-33)48(7,8)38-28-32(20-24-40(38)49(41)9)50-42-16-12-10-14-34(42)46(3,4)35-15-11-13-17-43(35)50;1-30-20-22-34(23-21-30)44(33-18-12-7-13-19-33)36-25-27-40-38(29-36)41(2,3)37-28-35(24-26-39(37)42(40)4)43(31-14-8-5-9-15-31)32-16-10-6-11-17-32;1-24-12-16-32-36(20-24)44-37-21-25(2)13-17-33(37)42(32)27-15-19-29-39(23-27)45-38-22-26(14-18-28(38)40(29)3)41-30-8-4-6-10-34(30)43-35-11-7-5-9-31(35)41;1-28-18-20-32(21-19-28)41(31-16-10-5-11-17-31)34-23-25-36-38(27-34)42-37-26-33(22-24-35(37)39(36)2)40(29-12-6-3-7-13-29)30-14-8-4-9-15-30;1-38-36-24-22-32(39(28-14-6-2-7-15-28)29-16-8-3-9-17-29)26-34(36)35-27-33(23-25-37(35)38)40(30-18-10-4-11-19-30)31-20-12-5-13-21-31;1-23-12-17-27(18-13-23)34(26-8-4-3-5-9-26)28-19-14-24(15-20-28)25-16-21-32-30(22-25)29-10-6-7-11-31(29)33(32)2/h6-35H,1-5H3;10-29H,1-9H3;5-29H,1-4H3;4-23H,1-3H3;3-27H,1-2H3;2-27H,1H3;3-22H,1-2H3
InChIKeyAFBHCAFVFBRCMD-UHFFFAOYSA-N
XLogP80.34
TPSA106.79 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds30
Heavy Atoms314
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004073.28
LogP ≤ 580.34
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Analyze 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine?
The IUPAC name of 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine (CID 157094623) is 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine.
What is the SMILES notation for 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine?
The canonical SMILES for 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine is Cc1ccc(N(c2ccccc2)c2ccc(-c3ccc4c(c3)c3ccccc3n4C)cc2)cc1.Cc1ccc(N(c2ccccc2)c2ccc3c(c2)C(C)(C)c2cc(N(c4ccccc4)c4ccccc4)ccc2N3C)cc1.Cc1ccc(N(c2ccccc2)c2ccc3c(c2)Oc2cc(N(c4ccccc4)c4ccccc4)ccc2N3C)cc1.Cc1ccc2c(c1)C(C)(C)c1cc(C)ccc1N2c1ccc2c(c1)C(C)(C)c1cc(N3c4ccccc4C(C)(C)c4ccccc43)ccc1N2C.Cc1ccc2c(c1)Oc1cc(C)ccc1N2c1ccc2c(c1)Oc1cc(N3c4ccccc4Oc4ccccc43)ccc1N2C.Cn1c2ccc(-c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)cc2c2cc(-c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)ccc21.Cn1c2ccc(N(c3ccccc3)c3ccccc3)cc2c2cc(N(c3ccccc3)c3ccccc3)ccc21.
What is the InChIKey of 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine?
The InChIKey is AFBHCAFVFBRCMD-UHFFFAOYSA-N. The full InChI is InChI=1S/C55H45N3.C48H47N3.C41H37N3.C39H29N3O3.C38H31N3O.C37H29N3.C32H26N2/c1-54(2)44-14-6-10-18-50(44)57(51-19-11-7-15-45(51)54)40-28-22-36(23-29-40)38-26-32-48-42(34-38)43-35-39(27-33-49(43)56(48)5)37-24-30-41(31-25-37)58-52-20-12-8-16-46(52)55(3,4)47-17-9-13-21-53(47)58;1-30-18-22-44-36(26-30)47(5,6)37-27-31(2)19-23-45(37)51(44)33-21-25-41-39(29-33)48(7,8)38-28-32(20-24-40(38)49(41)9)50-42-16-12-10-14-34(42)46(3,4)35-15-11-13-17-43(35)50;1-30-20-22-34(23-21-30)44(33-18-12-7-13-19-33)36-25-27-40-38(29-36)41(2,3)37-28-35(24-26-39(37)42(40)4)43(31-14-8-5-9-15-31)32-16-10-6-11-17-32;1-24-12-16-32-36(20-24)44-37-21-25(2)13-17-33(37)42(32)27-15-19-29-39(23-27)45-38-22-26(14-18-28(38)40(29)3)41-30-8-4-6-10-34(30)43-35-11-7-5-9-31(35)41;1-28-18-20-32(21-19-28)41(31-16-10-5-11-17-31)34-23-25-36-38(27-34)42-37-26-33(22-24-35(37)39(36)2)40(29-12-6-3-7-13-29)30-14-8-4-9-15-30;1-38-36-24-22-32(39(28-14-6-2-7-15-28)29-16-8-3-9-17-29)26-34(36)35-27-33(23-25-37(35)38)40(30-18-10-4-11-19-30)31-20-12-5-13-21-31;1-23-12-17-27(18-13-23)34(26-8-4-3-5-9-26)28-19-14-24(15-20-28)25-16-21-32-30(22-25)29-10-6-7-11-31(29)33(32)2/h6-35H,1-5H3;10-29H,1-9H3;5-29H,1-4H3;4-23H,1-3H3;3-27H,1-2H3;2-27H,1H3;3-22H,1-2H3.
What are the key properties of 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine?
10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine has a molecular weight of 4073.28 g/mol, XLogP of 80.34, 30 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[4-[6-[4-(9,9-dimethylacridin-10-yl)phenyl]-9-methylcarbazol-3-yl]phenyl]-9,9-dimethylacridine;2-(9,9-dimethylacridin-10-yl)-9,9,10-trimethyl-7-(2,7,9,9-tetramethylacridin-10-yl)acridine;3,7-dimethyl-10-(10-methyl-7-phenoxazin-10-ylphenoxazin-3-yl)phenoxazine;4-methyl-N-[4-(9-methylcarbazol-3-yl)phenyl]-N-phenylaniline;10-methyl-3-N-(4-methylphenyl)-3-N,7-N,7-N-triphenylphenoxazine-3,7-diamine;9-methyl-3-N,3-N,6-N,6-N-tetraphenylcarbazole-3,6-diamine;9,9,10-trimethyl-7-N-(4-methylphenyl)-2-N,2-N,7-N-triphenylacridine-2,7-diamine is sourced from PubChem (CID 157094623), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).